
India–US pharmaceutical trade is facing fresh challenges as the United States’ recent tariff policies, particularly those targeting Indian pharmaceutical exports, have sparked intense debate within the global healthcare industry. Indian drug makers, who supply nearly 40% of the generic drugs consumed in the US, are sounding alarms over the potential...









